THERIVA BIOLOGICS INC (TOVX) Stock Income Statement
NYSEARCA:TOVX - NYSE Arca - US87164U5083 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Operating Expenses | 18.45M | 19.43M | 21.43M | 21.38M | 14.27M | |||
| Research and Development | 11.54M | 12.03M | 14.31M | 11.72M | 7.80M | |||
| Selling, General, and Administrative Expenses | 6.91M | 7.40M | 6.42M | 7.56M | 6.47M | |||
| Operating Income | -18.45M | -19.43M | -21.43M | -21.38M | -14.27M | |||
| Interest Income/Expense | 559.00K | 693.00K | 1.44M | 470.00K | 10.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | -6.92M | 0.00 | -200.00K | N/A | |||
| Income Before Taxes | -24.81M | -25.65M | -19.99M | -21.11M | -14.27M | |||
| Income Tax | N/A | 0.00 | -1.64M | -1.43M | N/A | |||
| Net Income | -24.81M | -25.65M | -18.35M | -20.03M | -23.19M | |||
| EBITDA | -18.33M | -19.29M | -21.30M | -21.29M | -14.18M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -20.68 | -19.03 | -1.14 | -1.31 | -1.90 | |||
| Non GAAP EPS | N/A | N/A | -29.25 | -31.75 | -52.50 | |||
| Statistics | ||||||||
All data in USD